CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17

CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17

Summary: Accumulation of CD103+CD8+ resident memory T (TRM) cells in human lung tumors has been associated with a favorable prognosis. However, the contribution of TRM to anti-tumor immunity and to the response to immune checkpoint blockade has not been clearly established. Using quantitative multip...

Full description

Bibliographic Details
Main Authors: Stéphanie Corgnac, Ines Malenica, Laura Mezquita, Edouard Auclin, Elodie Voilin, Jamila Kacher, Heloise Halse, Laetitia Grynszpan, Nicolas Signolle, Thibault Dayris, Marine Leclerc, Nathalie Droin, Vincent de Montpréville, Olaf Mercier, Pierre Validire, Jean-Yves Scoazec, Christophe Massard, Salem Chouaib, David Planchard, Julien Adam, Benjamin Besse, Fathia Mami-Chouaib
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Cell Reports Medicine
Subjects:
CD8 TRM cells
CTL
Tc17
lung cancer
anti-PD-1 immunotherapy
tumor-infiltrating lymphocytes
Online Access:http://www.sciencedirect.com/science/article/pii/S2666379120301695

Internet

http://www.sciencedirect.com/science/article/pii/S2666379120301695

Similar Items